Background Prevalence surveys have shown that men aged over 40 commonly experience lower urinary tract symptoms (LUTS). However, such studies cannot be used in isolation to inform health service planning, as not all men are troubled by their symptoms nor would they necessarily benefit from treatment.
Introduction
Lower urinary tract symptoms (LUTS) are experienced by many men in the community [1] [2] [3] [4] [5] [6] and are viewed by many as part of the normal process of ageing. 7 Other men consider that their symptoms are troublesome, interfering with their quality of life. 8 The extent that men are bothered by their symptoms may be in part culturally determined, 9 but it also appears that some symptoms, such as post-micturition dribble, are viewed as particularly bothersome, whereas others, such as frequency of micturition, are less so.
Since the early 1990s, when transurethral resection of the prostate (TURP) for the treatment of LUTS was the most commonly performed surgical procedure in elderly men in England, 11 there have been considerable changes in the management of this condition. Many effective alternatives to TURP exist, 12 which has led to a growing recognition of the importance of primary care in the management of this condition, [13] [14] [15] and a marked decline in the use of invasive interventions has been reported in the United States. 16 Guidelines 17 and consensus panels 18 have concluded that there are few absolute indications for prostatectomy, and that decisions about treatment should be based on a number of factors including the level of urinary symptoms, the extent to which men are bothered by these, flow rate studies, a history of acute retention of urine and men's preferences.
This background makes estimating a population's health care needs for LUTS complex. However, it is an important problem given the ageing population and the need to ensure that the treatment men receive is the most appropriate. A model of a population's need for prostatectomy has been reported, 19 although the authors found that estimates of need were highly dependent on assumptions that were made about indications for intervention.
To overcome this problem, we undertook a populationbased epidemiological study that directly estimated the number of men who had a 'need' for treatment of LUTS in either primary or secondary care that was not being currently met.
Estimating a population's needs for the treatment of lower urinary tract symptoms in men: what is the extent of unmet need?
Subjects and methods
For the purposes of this study we considered that men had a need for treatment if they met all the following conditions: they reported a moderate or severe level of symptoms [scoring eight and over on the American Urological Association (AUA) symptom score 20 ]; they were bothered by their symptoms; and a consultant urologist considered that they would be likely to benefit from treatment.
A random sample of 3540 men aged 40 and over was drawn from the general practice population register held by Somerset Health Authority in 1995-1996. We sent each man a questionnaire containing the AUA symptom index, which has been extensively validated and adopted as the basis of the International Prostate Symptom Score 21 and asked about previous treatment for urinary problems. To encourage response, we sent non-responders two reminder letters with copies of the questionnaire at intervals of 4 weeks. Responders and nonresponders were compared by age and place of residence.
A research nurse contacted all men with an AUA score of eight and over and offered them an out-patient appointment for the assessment of their urinary symptoms. Men were excluded from the study at this stage only if they were unable to give consent for participation, had severe coexisting medical problems such that their general practitioner (GP) considered investigation or intervention was inappropriate or they were under the active care of a consultant urologist.
Men attending for assessment were asked to record the bothersomeness of their urinary symptoms using a developmental version of the ICS-male questionnaire, which was sent to men 1 week before their clinic assessment. This measure has been extensively validated 22, 23 and records the bother that men attribute to individual symptoms 10 and the impact on overall quality of life. 24 At the clinical assessment, men had their peak urinary flow rates recorded using a 'Dantec Urodyn 100' flowmeter and the residual volume of urine in the bladder after voiding was measured using a 'Bard Bladderscan' ultrasound instrument. Peak flow measurements were repeated if men failed to void 150 ml or the flow rate was less than 15 ml/s. Urinalysis for blood, glucose and protein was performed, with urine culture if clinically indicated.
Each man's symptom score, the extent to which he was troubled by his symptoms and clinical investigations were reviewed by one of the four consultant urologists in Somerset. The consultant reviewing the man's results made recommendations to his GP on further management options. All consultants followed published guidelines 17 and subjects were grouped into three categories depending on their results: (1) no treatment indicated -moderate level of symptoms (AUA score [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] and flow rate more than 15 ml/s; (2) recommendation that the subject many benefit from a discussion of his symptoms with his GP with a view to initiation of drug treatment or watchful waitingmoderate or severe degree of symptoms with a moderate reduction in flow rate between 10 and 15 ml/s; (3) recommendation that the subject may benefit from referral to secondary care to discuss the possibility of surgical intervention -moderate or severe symptoms with a flow rate of less than 10 ml/s. We did not use a level of symptom score to distinguish between the last two categories, as other factors such as the bother that men attributed to their symptoms, patient concerns and co-morbidity also influenced the recommendations.
A summary of the clinical findings and consultant's recommendations were sent to each participant and their GP. Ethical approval for the study was granted by the relevant district ethics committees.
Statistical analysis consisted of frequency distributions, with calculation of age-specific prevalence rates for mild, moderate and severe urinary symptoms. The ICS-male and ICS-QOL questionnaires were analysed using published methods.
10,24
The population's treatment needs were calculated as the product of the age-specific rates of moderate and severe urinary symptoms and the proportion of men in each age group reporting that their urinary symptoms interfere with their life somewhat or a lot (ICS-male question 30 24 ) and who were assessed as being likely to benefit from treatment. The resulting rates were directly standardized to the European standard population. As this rate is the product of two rates, calculation of the 95 per cent confidence interval (CI) is statistically complex. An approximation was made by treating it as a single directly standardized rate, using standard methods to calculate the 95 per cent CI. 25 A correction factor was applied to the denominator to allow for the effect of non-response in the two phases of the study. Figure 1 summarizes the study design and the number of men included at each stage. Of the 3540 men on the Health Authority general practice register, 18 had died or were unknown at their address, giving a study population of 3442. The response rate for the first stage of the study was 70 per cent although responders were under-represented in age groups between 40 and 55 years and over 80 ( Table 1) .
Results

Characteristics of the sample
Comparison of men who agreed to attend for clinical assessment with those who refused to attend or could not be contacted is shown in Table 2 . The two groups do not differ significantly in terms of AUA score severity, coexisting medical problems or experience of urological surgery. However, attenders were more likely to be aged between 50 and 80.
Prevalence of urinary symptoms in the community
AUA scores were categorized into mild (0-7), moderate (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) and severe (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . Overall, 256 men per 1000 (95 per cent CI 239-274) reported moderate or severe symptoms, with a marked increase by age from 40 to 79 (Table 3 ).
Impact of moderate or severe urinary symptoms on quality of life
Of the 388 men with moderate or severe urinary symptoms who attended for clinical assessment, 96 per cent had experienced symptoms for more than 1 year. Table 4 
Population need for treatment in primary or secondary care
The numbers of men who met the case definition for this study and are considered to have a need for treatment are shown in Table 5 . There is a considerable difference in the population's need for treatment depending on whether we include men who report that their symptoms interfere with life to any degree, or whether we include men who report more severe interference with life (see Table 5 ). The resulting rates, directly standardized to the European Standard Population, show that 66.2 per 1000 men aged 40 and over could benefit from treatment in primary care (95 per cent CI 54.6-77.8), if we include all men who report that their symptoms interfere with their life. However, it is reasonable to assume that those men who report a more severe impact of symptoms on their life are more likely to be offered and accept treatment. It follows that if the number who need treatment in secondary care is based on men who consider their symptoms trouble them 'somewhat or a lot', then the popula- tion rate needing treatment in secondary care is 9.0 per 1000 men aged 40 and over (95 per cent CI 4.9-13.1 per 1000).
Use of health services
The community prevalence survey showed that 9.9 per cent (237/2405) of responders report having had previous prostate surgery. Experience of surgery increased with age from 1 per cent in men aged 40-45, to 37 per cent for men aged 80 years and over. Of the men who had undergone surgery, 60 per cent were over 70 years.
More detailed information on health service usage is available on the subgroup of men with moderate or severe symptoms, attending for clinical assessment. Forty per cent of clinic attenders (156 men) had consulted their GP about their urinary difficulties, of whom 42 per cent (65 men) had been referred to a consultant. Men who had seen their GPs had higher AUA scores and were more likely to consider their urinary symptoms to be bothersome than those that had not seen their GP.
Discussion and conclusions
Before interpreting these results further, it is important to consider their validity and the extent that they can be generalized to the wider population. Study participants were underrepresented in the younger and older age groups compared with Possible responses to the question 'Overall, how much do your urinary symptoms interfere with your life?' were 'not at all', 'a little', 'somewhat', 'a lot'.
the Somerset population, although there was no difference in terms of previous urological surgery, AUA score or coexisting morbidity between men who attended for clinical assessment and those who did not. It has been reported that participation in studies of this nature is driven by concerns about urinary symptoms 26 and it is possible that the study participants are those men who are most likely to request treatment for their symptoms.
We used the ICS-QOL question 30 ('Overall, how much do your urinary symptoms interfere with your life? Not at all/A little/Somewhat/A lot') to indicate whether men were bothered by their symptoms. It has been shown that responses to this question are strongly related to the severity of many LUTS and other generic quality of life measures. 24 However, we did not directly ask men whether they would choose treatment for their symptoms, as no question has been adequately validated for this purpose.
One of the strengths of this study was that we used practising consultant urologists to recommend the most appropriate treatment options for each man. All consultants followed existing guidelines 17 and practice was consistent with recent referral guidelines produced by the National Institute for Clinical Excellence (NICE). 15 However, consultants were unable to give absolute decisions on treatment options, as these decisions are in part dependent on patients' preferences and it is well recognized that many factors influence appropriateness of referral to secondary care. 27 Therefore the group of men who were categorized as being able to benefit from primary care intervention will include men who will choose drug treatment or watchful waiting, whereas the secondary care group will contain some men who choose surgical intervention and some who decide with the consultant that other treatment options are preferable. It follows that this study gives an estimate of the total workload for each setting; prostatectomy and drug treatment rates will be less than these figures. The prevalence of urinary symptoms in our population is similar to that found in earlier studies, [1] [2] [3] [4] [5] [6] although direct comparisons are not straightforward as different case definitions and age groups have been studied. It is unclear why we found a fall in the rate of severe symptoms in men aged 80 and over. Numbers are small and should be interpreted with caution, but this may reflect a low response rate from men with poor general health, or may be a healthy survivor effect or the result of previous medical intervention.
We derived two estimates of the level of need for treatment within our population, dependent on whether we included all men who considered their symptoms interfered with their life or included only those men who considered they were affected 'somewhat' or 'a lot'. Including men who were only a little affected made a large difference to the estimate of need and it is likely that many of these men would decline treatment if offered.
Applying these rates to a 'typical' health authority with a population of 250 000 based on the European Standard popula- 19 to estimate the need for prostatectomy in a typical health district. Their estimates of prevalent need ranged from 400 to 2980 depending on the assumptions made about indications for treatment.
Our work clearly shows that although urinary symptoms are frequently experienced by men in the community, only a small proportion of these men are likely to benefit from treatment as well as being bothered by their symptoms sufficiently to request or accept treatment. This provides strong evidence to support the concept of finite need for services and shows that appropriately designed epidemiological studies can be used to measure a population's needs for treatment, to inform commissioning and planning of services.
